| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |